kanamycin a has been researched along with Cytomegalovirus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isomura, H; Iwahori, S; Kudoh, A; Nakayama, S; Sato, Y; Stinski, MF; Tsurumi, T | 1 |
| Jahn, G; Plachter, B; Wolff, D | 1 |
| Delannoy, AS; Hober, D; Lobert, PE; Wattré, P | 1 |
3 other study(ies) available for kanamycin a and Cytomegalovirus
| Article | Year |
|---|---|
The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis.
Topics: Binding Sites; Cytomegalovirus; DNA-Binding Proteins; DNA-Directed DNA Polymerase; DNA, Viral; Fibroblasts; Humans; Kanamycin; Models, Genetic; Mutagenesis; Mutation; Promoter Regions, Genetic; Ribonucleases; TATA-Box Binding Protein; Viral Proteins; Virus Replication | 2007 |
Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene.
Topics: Blotting, Southern; Cells, Cultured; Cytomegalovirus; DNA, Viral; Genes, Bacterial; Humans; Kanamycin; Kanamycin Kinase; Mutagenesis, Site-Directed; Phenotype; Phosphorylation; Phosphotransferases; Recombination, Genetic | 1993 |
Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts.
Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cytomegalovirus; Fibroblasts; Gentamicins; Humans; Kanamycin; Neomycin; Streptomycin | 1996 |